GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 18, 2024 |
PDB ID | UniProt ID | Title ▼ | Descriptor |
---|---|---|---|
5LKG | A0A0E4B1P1 | Protruding domain of GII.17 norovirus Kawasaki308 in complex with 2-fucosyllactose (2'FL) | |
5N7M | Q83884 | Protruding domain of GI.1 norovirus in complex with 2-fucosyllactose (2FL) | |
8UUO | P0DTC2 | Prototypic SARS-CoV-2 spike (containing V417) in the open conformation | |
8UUN | P0DTC2 | Prototypic SARS-CoV-2 spike (containing V417) in the closed conformation | |
8UUM | P0DTC2 | Prototypic SARS-CoV-2 spike (containing K417) in the open conformation | |
8UUL | P0DTC2 | Prototypic SARS-CoV-2 spike (containing K417) in the closed conformation | |
7TGX | P0DTC2 | Prototypic SARS-CoV-2 G614 spike (open form) | |
7TGY | P0DTC2 | Prototypic SARS-CoV-2 G614 spike (closed form) | |
6WP8 | 6WP8 | Proton-pumping mutant of Mastigocladopsis repens rhodopsin chloride pump | |
7RGF | Q91XX0 | Protocadherin gammaC4 EC1-4 crystal structure disrupted trans interface | |
7JGZ | Q91XX0 | Protocadherin gammaC4 EC1-4 crystal structure | |
5V5X | Q91XX3 | Protocadherin gammaB7 EC3-6 cis-dimer structure | |
5SZN | Q91XX9 | Protocadherin gamma A9 extracellular cadherin domains 1-5 | |
5SZM | Q91XY0 | Protocadherin gamma A8 extracellular cadherin domains 1-4 | |
5SZL | A0A0A6YW27 | Protocadherin gamma A1 extracellular cadherin domains 1-4 | |
5DZY | A8E4K6 | Protocadherin beta 8 extracellular cadherin domains 1-4 | |
5DZX | B2RWV0 | Protocadherin beta 6 extracellular cadherin domains 1-4 | |
5DZV | Q91Y13 | Protocadherin alpha 7 extracellular cadherin domains 1-5 | |
5DZW | O88689 | Protocadherin alpha 4 extracellular cadherin domains 1-4 | |
5SZO | Q91XX3 | Protocadherin Gamma B7 extracellular cadherin domains 1-4 P41212 crystal form | |
5SZP | Q91XX3 | Protocadherin Gamma B7 extracellular cadherin domains 1-4 P21 crystal form | |
5SZR | Q91XX7 | Protocadherin Gamma B2 extracellular cadherin domains 3-6 | |
5T9T | Q8K486 | Protocadherin Gamma B2 extracellular cadherin domains 1-5 | |
5SZQ | Q91XY4 | Protocadherin Gamma A4 extracellular cadherin domains 3-6 | |
2AOS | 19526603 | Protein-protein Interactions of protective signalling factor: Crystal structure of ternary complex involving signalling protein from goat (SPG-40), tetrasaccharide and a tripeptide Trp-pro-Trp at 2.9 A resolution | |
2AOS | 2AOS | Protein-protein Interactions of protective signalling factor: Crystal structure of ternary complex involving signalling protein from goat (SPG-40), tetrasaccharide and a tripeptide Trp-pro-Trp at 2.9 A resolution | |
6QXP | O48809 | Protein peptide complex | |
6QXP | Q9FZA0 | Protein peptide complex | |
6QWN | Q9LJ64 | Protein peptide complex | |
6QWN | Q9FZA0 | Protein peptide complex | |
3E37 | P49354 | Protein farnesyltransferase complexed with bisubstrate ethylenediamine scaffold inhibitor 5 | |
3E37 | P49356 | Protein farnesyltransferase complexed with bisubstrate ethylenediamine scaffold inhibitor 5 | |
3RDK | C6CRV0 | Protein crystal structure of xylanase A1 of Paenibacillus sp. JDR-2 | |
4GG6 | P01909 | Protein complex | |
4GG6 | P01920 | Protein complex | |
4GG6 | 4GG6 | Protein complex | |
4GG6 | P18573 | Protein complex | |
1TN6 | P49354 | Protein Farnesyltransferase Complexed with a Rap2a Peptide Substrate and a FPP Analog at 1.8A Resolution | |
1TN6 | P49356 | Protein Farnesyltransferase Complexed with a Rap2a Peptide Substrate and a FPP Analog at 1.8A Resolution | |
1TN6 | 1TN6 | Protein Farnesyltransferase Complexed with a Rap2a Peptide Substrate and a FPP Analog at 1.8A Resolution | |
2H6F | P49354 | Protein Farnesyltransferase Complexed with a Farnesylated DDPTASACVLS Peptide Product at 1.5A Resolution | |
2H6F | P49356 | Protein Farnesyltransferase Complexed with a Farnesylated DDPTASACVLS Peptide Product at 1.5A Resolution | |
2H6F | 2H6F | Protein Farnesyltransferase Complexed with a Farnesylated DDPTASACVLS Peptide Product at 1.5A Resolution | |
8VIA | P0DTC2 | Protective effect of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination | |
8VIA | 8VIA | Protective effect of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination | |
3VKL | O00214 | Protease-resistant mutant form of human Galectin-8 in complex with two lactose molecules | |
3VKM | O00214 | Protease-resistant mutant form of Human Galectin-8 in complex with sialyllactose and lactose | |
3ICU | Q8TEB7 | Protease-associated domain of the E3 ligase grail | |
7EOX | 7EOX | Protease structure from Euphorbia resinifera | |
1YBW | Q04756 | Protease domain of HGFA with no inhibitor |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024